Losses of chromosome arms 4q, 8p, 13q and gain of 8q are correlated with increasing chromosomal instability in hepatocellular carcinoma

Pathobiology

Volumn 75, Issue 5, 2008, Pages 312-322

  Hertz, Sabine ^a   Rothämel, Thomas ^a   Skawran, Britta ^a   Giere, Christian ^a   Steinemann, Doris ^a   Flemming, Peer ^a   Becker, Thomas ^a   Flik, Jacobus ^a   Wiese, Birgit ^a   Soudah, Bisharah ^a   Kreipe, Hans ^a   Schlegelberger, Brigitte ^a   Wilkens, Ludwig ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Chromosomal instability; Comparative genomic hybridization; Fluorescence in situ hybridization; Hepatocellular carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CELL NUCLEUS; CHROMOSOMAL INSTABILITY; CHROMOSOME 1; CHROMOSOME 13Q; CHROMOSOME 17; CHROMOSOME 3; CHROMOSOME 4Q; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; POLYPLOIDY; PRIORITY JOURNAL; SCHOOL CHILD; STRUCTURAL CHROMOSOME ABERRATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHILD; CHROMOSOMAL INSTABILITY; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 4; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYPLOIDY; YOUNG ADULT;

EID: 54249160972     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151712     Document Type: Article

References (38)

1. Bosch F, Munoz N: Hepatocellular carcinoma in the world: epidemiologic questions. Adv Appl Biotechnol 1991;13:55-56.
2. Schirmacher P, Dienes HP: Hepatocellular carcinoma;in Kurzrock R, Talpaz M (eds): Molecular Biology in Cancer Medicine. London, Dunitz, 1999, pp 355-366.
3. Ozturk M: p53 mutations in hepatocellular carcinoma after aflatoxin exposure. Lancet 1991;338:1356-1359.
4. Nishida N, Fukuda Y, Kokuryu H, Sadamoto T, Isowa G, Honda K, Yamaoka Y, Ikenaga M, Imura H, Ishizaki K: Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma. Int J Cancer 1992;51:862-868.
5. Schirmacher P, Held WA, Yang D, Chisari FV, Rustum Y, Rogler CE: Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth. Cancer Res 1992;52:2549-2556.
6. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH: Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res 1987;47:707-712.
7. Kusano N, Okita K, Shirahashi H, Harada T, Shiraishi K, Oga A, Kawauchi S, Furuya T, Sasaki K: Chromosomal imbalances detected by comparative genomic hybridization are associated with outcome of patients with hepatocellular carcinoma. Cancer 2002;94:746-751.
8. Laurent-Puig P, Legoix P, Bluteau O, Belghiti J, Franco D, Binot F, Monges G, Thomas G, Bioulac-Sage P, Zucman-Rossi J: Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology 2001;120:1763-1773.
9. Moinzadeh P, Breuhahn K, Stutzer H, Schirmacher P: Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade - results of an explorative CGH meta-analysis. Br J Cancer 2005;92:935-941.
10. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo WL, Chen C, Zhai Y, Dairkee SH, Ljung BM, Gray JW, Albertson DG: High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998;20:207-211.
11. Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, Williams CF, Jeffrey SS, Botstein D, Brown PO: Genomewide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 1999;23:41-46.
12. Wilkens L, Flemming P, Gebel M, Bleck J, Terkamp C, Kreipe H, Schlegelberger B: Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma. Proc Natl Acad Sci USA 2004;101:1309-1314.
13. Ishak KG, Anthony PP, Sobin LH: Histological Typing of Tumours of the Liver, ed 2. Geneva, WHO, 1994.
14. Steinemann D, Skawran B, Becker T, Tauscher M, Weigmann A, Wingen L, Tauscher S, Hinrichsen T, Hertz S, Flemming P, Flik J, Wiese B, Kreipe H, Lichter P, Schlegelberger B, Wilkens L: Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization. Clin Gastrohepatol 2006;4:1283-1291.
15. Skawran B, Steinemann D, Weigmann A, Becker T, Flik J, Kreipe H, Schlegelberger B, Wilkens L: Gene expression profiling in hepatocelluar carcinoma: coordinated upregulation of genes localised in amplified chromosome regions. Mod Pathol 2008;21:505-516.
16. Wilkens L, Gerr H, Gadzicki D, Kreipe H, Schlegelberger B: Standardized fluorescence in situ hybridisation in cytological and histological specimens. Virchows Arch 2005;447:586-592.
17. Park SJ, Jeong SY, Kim HJ: Y chromosome loss and other genomic alterations in hepatocellular carcinoma cell lines analyzed by CGH and CGH array. Cancer Genet Cytogenet 2006;166:56-64.
18. von Wasielewski R, Mengel M, Gignac S, Wilkens L, Werner M, Georgii A: Tyramine amplification technique in routine immunohistochemistry. J Histochem Cytochem 1997;45:1455-1459.
19. Ward BE, Gersen SL, Carelli MP, McGuire NM, Dackowski WR, Weinstein M, Sandlin C, Warren R, Klinger KW: Rapid prenatal diagnosis of chromosomal aneuploidies by fluorescence in situ hybridization: clinical experience with 4,500 specimens. Am J Hum Genet 1993;52:854-865.
20. Marchio A, Meddeb M, Pineau P, Danglot G, Tiollais P, Bernheim A, Dejean A: Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 1997;18:59-65.
21. Wong N, Lai P, Lee SW, Fan S, Pang E, Liew CT, Sheng Z, Lau JW, Johnson PJ: Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis. Am J Pathol 1999;154:37-43.
22. Kusano N, Shiraishi K, Kubo K, Oga A, Okita K, Sasaki K: Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features. Hepatology 1999;29:1858-1862.
23. Wilkens L, Bredt M, Flemming P, Schwarze Y, Becker T, Mengel M, von Wasielewski R, Klempnauer J, Kreipe H: Diagnostic impact of fluorescence in situ hybridization in the differentiation of hepatocellular adenoma and well-differentiated hepatocellular carcinoma. J Mol Diagn 2001;3:68-73.
24. Cottier M, Jouffre C, Maubon I, Sabido O, Barthelemy C, Cuilleron M, Veyret C, Laurent JL, Audigier JC: Prospective flow cytometric DNA analysis of hepatocellular carcinoma specimens collected by ultrasoundguided fine needle aspiration. Cancer 1994;74:599-605.
25. Zeppa P, Benincasa G, Troncone G, Lucariello A, Zabatta A, Cochand-Priollet B, Fulciniti F, Vetrani A, De Rosa G, Palombini L: Retrospective evaluation of DNA ploidy of hepatocarcinoma on cytologic samples. Diagn Cytopathol 1998;19:323-329.
26. Fujimoto J, Okamoto E, Yamanaka N, Toyosaka A, Mitsunobu M: Flow cytometric DNA analysis of hepatocellular carcinoma. Cancer 1991;67:939-944.
27. Yeh SH, Lin MW, Lu SF, Wu DC, Tsai SF, Tsai CY, Lai MY, Hsu HC, Chen DS, Chen PJ: Allelic loss of chromosome 4q21 approximately 23 associates with hepatitis B virus-related hepatocarcinogenesis and elevated alpha-fetoprotein. Hepatology 2004;40:847-854.
28. Lu T, Hano H: Identification of minimal regions of deletion at 8p23.1-22 associated with metastasis of hepatocellular carcinoma. Liver Int 2007;27:782-790.
29. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM: A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005;353:1793-1801.
30. Mertens F, Johansson B, Mitelman F: Isochromosomes in neoplasia. Genes Chromosomes Cancer 1994;10:221-230.
31. Adhikary S, Eilers M: Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 2005;6:635-645.
32. Hooker CW, Hurlin PJ: Of Myc and Mnt. J Cell Sci 2006;119:208-216.
33. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT: c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005;435:839-843.
34. Gupta S: Hepatic polyploidy and liver growth control. Semin Cancer Biol 2000;10:161-171.
35. Anatskaya OV, Vinogradov AE: Genome multiplication as adaptation to tissue survival: evidence from gene expression in mammalian heart and liver. Genomics 2007;89:70-80.
36. Ivanov A, Cragg MS, Erenpreisa J, Emzinsh D, Lukman H, Illidge TM: Endopolyploid cells produced after severe genotoxic damage have the potential to repair DNA double strand breaks. J Cell Sci 2003;116:4095-4106.
37. Guttenbach M, Koschorz B, Bernthaler U, Grimm T, Schmid M: Sex chromosome loss and aging: in situ hybridization studies on human interphase nuclei. Am J Hum Genet 1995;57:1143-1150.
38. Nagele R, Freeman T, McMorrow T, Lee HY: Precise spatial positioning of chromosomes during prometaphase: evidence for chromosomal order. Science 1995;270:1831-1835.